Investor'S Fiduciary Advisor Network, LLC Clearside Biomedical, Inc. Transaction History
Investor'S Fiduciary Advisor Network, LLC
- $212 Million
- Q1 2025
A detailed history of Investor'S Fiduciary Advisor Network, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Investor'S Fiduciary Advisor Network, LLC holds 33,800 shares of CLSD stock, worth $25,350. This represents 0.01% of its overall portfolio holdings.
Number of Shares
33,800
Previous 33,800
-0.0%
Holding current value
$25,350
Previous $32,000
3.13%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CLSD
# of Institutions
50Shares Held
11MCall Options Held
5.9KPut Options Held
86.6K-
Vanguard Group Inc Valley Forge, PA2.81MShares$2.1 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$1.65 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$1.13 Million0.02% of portfolio
-
Black Rock Inc. New York, NY798KShares$598,6020.0% of portfolio
-
Geode Capital Management, LLC Boston, MA792KShares$594,1850.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $45.1M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...